Sue Kim, PhD

Sue Kim, PhD portrait
  • Director, Personalized Active Learning (PAL)
  • Associate Professor, Basic Medical Sciences, Basic Medical Sciences
  • suwon@arizona.edu
    • Primary Address
    • Office
    • University of Arizona College of Medicine - Phoenix
    • ABC-1 Building
    • 425 North 5th Street
    • Phoenix, AZ, United States 85004

Publications

Publications

  • Peng S, Hebert LL, Eschbacher JM & Kim S (2020). Single-cell RNA sequencing of a postmenopausal normal breast tissue identifies multiple cell types that contribute to breast cancer. Cancers. Vol. 12(12), 3639-3659. Published, 12/04/2020.
  • Hendricks WPD, Briones N, Halperin RF, Facista S, Heaton PR, Mahadevan D & Kim S (2019). PD-1-Associated Gene Expression Signature of Neoadjuvant Trastuzumab-Treated Tumors Correlates with Patient Survival in HER2-Positive Breast Cancer. Cancers. Vol. 11(10), 1566-1521. Published, 10/15/2019.
  • Keenen MM & Kim S (2016). Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells. Breast Cancer. Vol. 8, 211-221. Published, 11/17/2016.
  • Kim S (2015). New and emerging factors in tumorigenesis: an overview. Cancer Manag Res. Vol. 7, 225-239. Published, 07/28/2015.
  • Byron SA, Min E, Thal TS, Tapia C, Hostetter G, Watanabe A, Azorsa D, Little TH & Kim S (2012). Attenuation of NF-kappa B by the ING4 tumor suppressor in breast cancer. PLoS One. Vol. 7(10). Published, 10/04/2012.
  • Tapia C, Zlobec I, Schneider S, Kilic E, Guth U, Bubendorf L & Kim S (2011). Deletion of the ING4 tumor suppressor gene is prevalent in HER2-positive breast cancer. Hum Pathol. Vol. 42(7), 983-990. Published, 07/2011.
  • Kim S, Welm AL & Bishop JM (2010). A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis. Cancer Res. Vol. 70, 5155-5162. Published, 07/15/2010.